NCT05642520 is a NA clinical trial of Oval section abutment of 2.9 mm in Dental Implants, sponsored by Ana María García de la Fuente.

Who is sponsoring NCT05642520?

NCT05642520 is sponsored by Ana María García de la Fuente.

What drugs are being tested in NCT05642520?

Interventions in NCT05642520: Oval section abutment of 2.9 mm, Circular section abutment of 3.3 mm.

What condition does NCT05642520 study?

NCT05642520 studies Dental Implants.

Is NCT05642520 still recruiting?

NCT05642520 is currently completed. Last updated 27 July 2023.

Last reviewed 2023-07-27 · How we verify

NCT05642520

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Oval Abutment Versus a Circular Abutment in Dental Implants in the Anterior Maxillae

Completed NA Last updated 27 July 2023

What this trial tests

NA trial testing Oval section abutment of 2.9 mm in Dental Implants in 40 participants. Completed in 1 March 2023.

Timeline

1 February 2018

Primary endpoint
1 February 2023

1 March 2023

Quick facts

Lead sponsor	Ana María García de la Fuente
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	non randomized
Design	parallel
Masking	triple
Primary purpose	treatment
Enrollment	40
Start date	1 February 2018
Primary completion	1 February 2023
Estimated completion	1 March 2023
Sites	1 location across Spain

Drugs / interventions tested

Oval section abutment of 2.9 mm
Circular section abutment of 3.3 mm

Conditions studied

Dental Implants — all drugs for Dental Implants →

Sponsor

Ana María García de la Fuente

Who can join

18 and older, any sex, with Dental Implants. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Objetive: The main objective of this clinical trial is to assess whether the oval section abutment of a 2.9mm implant achieves a greater covering of the tooth-implant papilla compared to a circular section abutment in 3.3mm implants in upper lateral incisors and lower central / lateral incisors. Material and methods: fourty patients received unitary implants of 3.3mm or 2.9 mm diameter to replace the absence of upper lateral incisor or lower central/lateral incisor with an edentulous space of at least 6.4mm (mesio-distally). Esthetic and clinical parameters were evaluated 12 months after installation of the prosthesis. Condition or disease: dental implants Intervention/treatment: 3.3 or 2.9 mm diameter dental implants Phase: Not Applicable

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Clinical analysis of the tooth-implant papilla for two narrow-diameter titanium-zirconium implants in the anterior area: prospective controlled clinical study.
Herrera-Pérez P, García-De-La-Fuente AM, Andia-Larrea E, Marichalar-Mendia X, et al · · 2024 · cited 2× · PMID 38443879 · DOI 10.1186/s12903-024-04075-2

Verify or expand the search:

Other recruiting trials for Dental Implants

Currently open trials in the same condition.

NCT07346391 — Augmentation of Peri-implant Keratinized Mucosa Using a Combination of Free Gingival Graft Strip With Platelet-Rich Fibr · NA · recruiting
NCT07073196 — Single Implant Crowns Supported by Narrow or Standard Diameter Implants in Molar Sites · NA · recruiting
NCT06808854 — Variable-thread Versus Standard Dental Implants for Replacing Missing Teeth · NA · recruiting
NCT07088679 — Natural Bioactive Gel for Peri-Implantitis · NA · recruiting
NCT06960460 — Study Evaluating the Performance and Safety in the Medium and Long Term of Global D ZygoFixU System · NA · recruiting

Other Ana María García de la Fuente trials

Trials by the same sponsor.

NCT06201377 — Analysis of Early Healing of Sutures in Periodontal Surgery · NA · enrolling by invitation

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05642520 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Ana María García de la Fuente
Last refreshed: 27 July 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05642520.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing